about
Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolutionUtility of the blood for gene expression profiling and biomarker discovery in chronic fatigue syndromeExercise responsive genes measured in peripheral blood of women with chronic fatigue syndrome and matched control subjectsChronic fatigue syndrome--a clinically empirical approach to its definition and studyIntegration of gene expression, clinical, and epidemiologic data to characterize Chronic Fatigue SyndromeValidation of array-based gene expression profiles by real-time (kinetic) RT-PCRA population-based study of the clinical course of chronic fatigue syndromeAnalysis of 16S rRNA gene sequences and circulating cell-free DNA from plasma of chronic fatigue syndrome and non-fatigued subjects.Regional distribution of fatiguing illnesses in the United States: a pilot studySleep assessment in a population-based study of chronic fatigue syndromeBioelectronic DNA detection of human papillomaviruses using eSensor: a model system for detection of multiple pathogensPsychometric properties of the CDC Symptom Inventory for assessment of chronic fatigue syndrome.Gene expression profile of cervical tissue compared to exfoliated cells: impact on biomarker discoveryPrevalence of HPV infection among females in the United StatesQuadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP)HPV genotypes in high grade cervical lesions and invasive cervical carcinoma as detected by two commercial DNA assays, North Carolina, 2001-2006Cross-sectional study of HPV-16 infection in a population-based subsample of Hispanic adults.Chemiluminescent analysis of gene expression on high-density filter arrays.Global amplification of sense RNA: a novel method to replicate and archive mRNA for gene expression analysis.Detection of human papillomavirus in archival tissues. Comparison of in situ hybridization and polymerase chain reaction.Human papillomavirus in amniotic fluid.Sleep characteristics of persons with chronic fatigue syndrome and non-fatigued controls: results from a population-based study.Perception versus polysomnographic assessment of sleep in CFS and non-fatigued control subjects: results from a population-based study.Optimization of SELDI-TOF protein profiling for analysis of cervical mucous.An evaluation of exclusionary medical/psychiatric conditions in the definition of chronic fatigue syndrome.Human papillomavirus genotype prevalence in invasive vaginal cancer from a registry-based populationUrine-based human papillomavirus DNA testing as a screening tool for cervical cancer in high-risk women.Human papillomavirus prevalence in oropharyngeal cancer before vaccine introduction, United StatesDecreased basal ganglia activation in subjects with chronic fatigue syndrome: association with symptoms of fatigue.Assessing the relationship between HIV infection and cervical cancer in Côte d'Ivoire: a case-control studyImplementation of exon arrays: alternative splicing during T-cell proliferation as determined by whole genome analysis.Chronic Fatigue Syndrome: The Current Status and Future Potentials of Emerging Biomarkers.Impact of HPV assay on observed population prevalence.Optimization of a human papillomavirus-specific enzyme-linked immunosorbent assay.Comparison of human papillomavirus detection and typing by cycle sequencing, line blotting, and hybrid capture.Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV typePrevalence of cervical and oral human papillomavirus infections among US womenIdentification of Phosphoglycerate Kinase 1 (PGK1) as a reference gene for quantitative gene expression measurements in human blood RNA.Minimum data elements for research reports on CFSShort duration of elevated vIRF-1 expression during lytic replication of human herpesvirus 8 limits its ability to block antiviral responses induced by alpha interferon in BCBL-1 cells.
P50
Q21254589-EBB8524E-1DD4-429C-99FF-325A94AB8ECBQ21342986-BD361C7F-6F46-4F1B-A690-682CDE975236Q24522299-EFBAE777-F995-4A9B-98B2-2252C1D54C15Q24536313-B50C4756-CC54-4C1B-95FD-C3D7378F28A4Q24603914-A4D52876-6280-4CA2-8EF5-A8032BC4CF21Q24680512-48F693BF-4657-40DD-BD6E-8B02E7BC3496Q24791084-53F4F553-FF34-4986-9E06-9A9885F4E9B4Q24795070-FCEE3A1D-F605-420D-A55A-4D640FA1AEA5Q24799448-044153FC-B1B1-4FEE-B49A-02D7046A3412Q24804093-11C70EC2-FBBD-44BC-B19C-35318C3DF66BQ24806061-B64CB604-ADB5-4439-A006-B7DE99E56842Q24811154-5A963F88-DB7A-4F7D-9E66-720C664422DDQ24814177-D77CDD82-2017-4343-8155-7EF71E535C78Q28290509-4A66840B-1966-4992-B367-F35C4E3684F1Q28294460-E9C9201E-3CE8-4D10-B3FA-D32FCC9D20D7Q28730863-8AAC43A8-3574-4971-8217-CB80ECEDF0C1Q30571320-EE3D592E-C246-4046-9DAA-D02D945F039BQ30636276-3589D14F-27E9-41D9-B83E-E676C6035C5CQ31166076-E92FD98A-9FAD-43FC-AA49-22559912D418Q32077762-AAFB6D59-4821-461A-9BCD-96958276E597Q33256322-E89AD640-5DF5-4476-92CE-614F629F25BFQ33263807-005AAD42-4662-4450-B511-0B85610F6115Q33308329-6E54806C-28D1-4DDA-AC7D-DFD999F3275AQ33390843-53D98096-695B-4B41-B22C-9B0F919A1655Q33509651-EACF6169-94FC-412A-A4BC-C091B28E67EEQ33563955-6CA21DB8-9B12-4FFB-9DF1-E890FCD66D29Q33566914-5D6E228F-14B1-48E5-BCC3-3937D8B0A041Q33577175-7EA7C59D-00F4-4190-A12E-947DD7015E24Q33654938-4AA99771-F57B-4FE1-BD49-13A9DC8834E8Q33661008-388A1443-9D3A-4246-996D-99741529B9F7Q33692455-0C9E939D-F4FB-4224-A379-B308546E8D8CQ33737919-08286C7D-0DCE-4D42-8B2B-0383B7093901Q33885647-8BB65EA6-E50F-415C-8DFF-F53EA4C52EDFQ33943463-04B3D0CE-CBC7-4C33-8036-F5E4E2366B06Q33965378-14798CE0-0EF3-4266-8D88-C2CE8F4D3A3AQ33974576-84AF78BF-372F-4674-B358-BBFA151E3D72Q34007201-7DC1A976-46D9-44A7-8484-DBBD62B76B41Q34012401-86D0EB2B-3658-4A39-9BBE-D296C9330259Q34151020-52DE8AF7-3F46-4823-8D6D-028096DD427BQ34192731-1886D64B-AA72-4463-83A3-808D6A242FDD
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Elizabeth R. Unger
@ast
Elizabeth R. Unger
@en
Elizabeth R. Unger
@es
Elizabeth R. Unger
@nl
Elizabeth R. Unger
@sl
type
label
Elizabeth R. Unger
@ast
Elizabeth R. Unger
@en
Elizabeth R. Unger
@es
Elizabeth R. Unger
@nl
Elizabeth R. Unger
@sl
altLabel
Elizabeth A. Robinson
@en
prefLabel
Elizabeth R. Unger
@ast
Elizabeth R. Unger
@en
Elizabeth R. Unger
@es
Elizabeth R. Unger
@nl
Elizabeth R. Unger
@sl
P106
P1153
7202579934
P21
P31
P496
0000-0002-2925-5635